Acasti Pharma Inc. announced it raised $373,000 in an initial filing from an offering of $838,000

Company

Location

About

Grace Therapeutics, Inc. was formerly known as Acasti Pharma Inc. Grace Therapeutics is a late-stage biopharma company with drug candidates addressing rare and orphan diseases. Our clinical assets have been awarded Orphan Drug Designation by the FDA, which provides seven years of marketing exclusivity post-launch in the United States. We have additional intellectual property protection with over 40 granted and pending patents.